Browse Drug Recalls
7 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 7 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 7 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Mar 11, 2013 | Piracetam & Choline, 390mg Piracetam 104mg Choline Capsules, a) 30 count bott... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | BoostYourGrade.com, Piracetam 390mg Choline 104mg capsules, 250 count bottle,... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 coun... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | Aniracetam & Choline capsules, 430mg Aniracetam 88mg Choline, a) 30 count bot... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | Oxiracetam & Choline , Oxiracetam 460mg Choline 110mg capsules a) 30 count bo... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | Brain Defogger, Piracetam 390mg Choline 104mg capsules, 100 count bottle, OTC... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | Aniracetam and Choline, Aniracetam 460 mg, Choline 76 mg, 180 capsules per bo... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.